Announced Fri, 26 Jun · 15:09 IST
Entero Healthcare board approves ESOP allotment and re-appoints two independent directors
Management Changes View source PDF
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹1180.00
prior close
₹1178.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.8-1.1-0.4+0.8+0.4+1.3+2.7+0.8+0.0+1.7———
Up moveDown movePending
AI summary
Entero Healthcare's board allotted 1,475 equity shares at Rs 804 each to an eligible employee under the ESOP 2023 plan. It also re-appointed independent directors Rajesh Shashikant Dalal and Sandhya Gadkari Sharma for a second 4-year term from August 25, 2026 to August 24, 2030, subject to shareholder approval at the AGM.
Likely market impact
Routine governance update. ESOP allotment is minor at 1,475 shares. Director re-appointments require shareholder approval at the upcoming AGM.